目次

Table of Contents

Chapter 1. Methodology And Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.1.2. Indication
1.1.3. Route of Administration
1.1.4. End Use
1.2. Regional Scope
1.3. Estimates And Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information Or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.9.2. Parent Market Analysis
1.10. List Of Secondary Sources
1.11. List Of Abbreviations

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Bispecific Antibody Therapeutics Contract Manufacturing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Ongoing Research Activities in Bispecific Antibody Therapeutics
3.2.1.2. Rapid success of bispecific antibody therapeutics in cancer and non-cancer programs
3.2.2. Market Restraint Analysis
3.2.2.1. Challenges associated with manufacturing of bispecific antibody therapeutics
3.3. Bispecific Antibody Therapeutics Contract Manufacturing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat Of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis

Chapter 4. Bispecific Antibody Therapeutics Contract Manufacturing Market: Indication Estimates & Trend Analysis
4.1. Bispecific Antibody Therapeutics Contract Manufacturing Market, By Indication: Segment Dashboard
4.2. Bispecific Antibody Therapeutics Contract Manufacturing Market, By Indication: Movement Analysis
4.3. Bispecific Antibody Therapeutics Contract Manufacturing Market Estimates & Forecasts, By Indication, 2018 - 2030
4.3.1. Cancer
4.3.1.1. Cancer Bispecific Antibody Therapeutics Contract Manufacturing Market, 2018 to 2030 (USD Million)
4.3.2. Infectious Diseases
4.3.2.1. Infectious Diseases Bispecific Antibody Therapeutics Contract Manufacturing Market, 2018 to 2030 (USD Million)
4.3.3. Autoinflammatory and Autoimmune Diseases
4.3.3.1. Autoinflammatory and Autoimmune Diseases Bispecific Antibody Therapeutics Contract Manufacturing Market, 2018 to 2030 (USD Million)
4.3.4. CNS Conditions
4.3.4.1. CNS Conditions Bispecific Antibody Therapeutics Contract Manufacturing Market, 2018 to 2030 (USD Million)
4.3.5. Others
4.3.5.1. Others Bispecific Antibody Therapeutics Contract Manufacturing Market, 2018 to 2030 (USD Million)

Chapter 5. Bispecific Antibody Therapeutics Contract Manufacturing Market: Route of Administration Estimates & Trend Analysis
5.1. Bispecific Antibody Therapeutics Contract Manufacturing Market, By Route of Administration: Segment Dashboard
5.2. Bispecific Antibody Therapeutics Contract Manufacturing Market, By Route of Administration: Movement Analysis
5.3. Bispecific Antibody Therapeutics Contract Manufacturing Market Estimates & Forecasts, By Route of Administration, 2018 - 2030
5.3.1. Intravenous
5.3.1.1. Intravenous Bispecific Antibody Therapeutics Contract Manufacturing Market, 2018 to 2030 (USD Million)
5.3.2. Subcutaneous
5.3.2.1. Subcutaneous Bispecific Antibody Therapeutics Contract Manufacturing Market, 2018 to 2030 (USD Million)
5.3.3. Others
5.3.3.1. Others Bispecific Antibody Therapeutics Contract Manufacturing Market, 2018 to 2030 (USD Million)

Chapter 6. Bispecific Antibody Therapeutics Contract Manufacturing Market: End-use Estimates & Trend Analysis
6.1. Bispecific Antibody Therapeutics Contract Manufacturing Market, By End-use: Segment Dashboard
6.2. Bispecific Antibody Therapeutics Contract Manufacturing Market, By End-use: Movement Analysis
6.3. Bispecific Antibody Therapeutics Contract Manufacturing Market Estimates & Forecasts, By End-use, 2018 - 2030
6.3.1. Pharmaceutical Companies
6.3.1.1. Pharmaceutical Companies Bispecific Antibody Therapeutics Contract Manufacturing Market 2018 to 2030 (USD Million)
6.3.2. Biopharmaceutical Companies
6.3.2.1. Biopharmaceutical Companies Bispecific Antibody Therapeutics Contract Manufacturing Market 2018 to 2030 (USD Million)
6.3.3. Others
6.3.3.1. Others Bispecific Antibody Therapeutics Contract Manufacturing Market 2018 to 2030 (USD Million)

Chapter 7. Bispecific Antibody Therapeutics Contract Manufacturing Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2022 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. North America
7.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. U.S. Market Estimates and Forecasts, 2018 - 2030
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Canada Market Estimates and Forecasts, 2018 - 2030
7.5. Europe
7.5.1. UK
7.5.1.1. Key Country Dynamics
7.5.1.2. Competitive Scenario
7.5.1.3. UK Market Estimates and Forecasts, 2018 - 2030
7.5.2. Germany
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Germany Market Estimates and Forecasts, 2018 - 2030
7.5.3. Rest of Europe
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Rest of Europe Market Estimates and Forecasts, 2018 - 2030
7.6. Asia Pacific
7.6.1. Japan
7.6.1.1. Key Country Dynamics
7.6.1.2. Competitive Scenario
7.6.1.3. Japan Market Estimates and Forecasts, 2018 - 2030
7.6.2. China
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. China Market Estimates and Forecasts, 2018 - 2030
7.6.3. Rest of Asia Pacific
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Rest of Asia Pacific Market Estimates and Forecasts, 2018 - 2030
7.7. Rest of Rest of the World

Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.1.1. Innovators
8.1.2. Market Leaders
8.1.3. Emerging Players
8.1.4. Company Market Share Analysis, 2022
8.2. Company Profiles
8.3. Company Profiles
8.3.1. Lonza
8.3.1.1. Company Overview
8.3.1.2. Financial Performance
8.3.1.3. Service Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. Roche's
8.3.2.1. Company Overview
8.3.2.2. Financial Performance
8.3.2.3. Service Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Creative Biolabs
8.3.3.1. Company Overview
8.3.3.2. Financial Performance
8.3.3.3. Service Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. AbbVie
8.3.4.1. Company Overview
8.3.4.2. Financial Performance
8.3.4.3. Service Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Amgen
8.3.5.1. Company Overview
8.3.5.2. Financial Performance
8.3.5.3. Service Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Janssen
8.3.6.1. Company Overview
8.3.6.2. Financial Performance
8.3.6.3. Service Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Johnson & Johnson
8.3.7.1. Company Overview
8.3.7.2. Financial Performance
8.3.7.3. Service Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. IQVIA
8.3.8.1. Company Overview
8.3.8.2. Financial Performance
8.3.8.3. Service Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. WuXi Biologics
8.3.9.1. Company Overview
8.3.9.2. Financial Performance
8.3.9.3. Service Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Sino Biological Inc
8.3.10.1. Company Overview
8.3.10.2. Financial Performance
8.3.10.3. Service Benchmarking
8.3.10.4. Strategic Initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 North America Bispecific Antibody Therapeutics Contract Manufacturing Market, by region, 2018 - 2030 (USD Million)
Table 4 North America Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration Type, 2018 - 2030 (USD Million)
Table 5 North America Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018 - 2030 (USD Million)
Table 6 North America Bispecific Antibody Therapeutics Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
Table 7 U.S. Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration Type, 2018 - 2030 (USD Million)
Table 8 U.S. Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018 - 2030 (USD Million)
Table 9 U.S. Bispecific Antibody Therapeutics Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
Table 10 Canada Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration Type, 2018 - 2030 (USD Million)
Table 11 Canada Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018 - 2030 (USD Million)
Table 12 Canada Bispecific Antibody Therapeutics Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
Table 13 Europe Bispecific Antibody Therapeutics Contract Manufacturing Market, by region, 2018 - 2030 (USD Million)
Table 14 Europe Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration Type, 2018 - 2030 (USD Million)
Table 15 Europe Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018 - 2030 (USD Million)
Table 16 Europe Bispecific Antibody Therapeutics Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
Table 17 UK Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration Type, 2018 - 2030 (USD Million)
Table 18 UK Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018 - 2030 (USD Million)
Table 19 UK Bispecific Antibody Therapeutics Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
Table 20 Germany Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration Type, 2018 - 2030 (USD Million)
Table 21 Germany Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018 - 2030 (USD Million)
Table 22 Germany Bispecific Antibody Therapeutics Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
Table 23 Rest of Europe Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration Type, 2018 - 2030 (USD Million)
Table 24 Rest of Europe Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018 - 2030 (USD Million)
Table 25 Rest of Europe Bispecific Antibody Therapeutics Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
Table 26 Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market, by region, 2018 - 2030 (USD Million)
Table 27 Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration Type, 2018 - 2030 (USD Million)
Table 28 Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018 - 2030 (USD Million)
Table 29 Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
Table 30 Japan Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration Type, 2018 - 2030 (USD Million)
Table 31 Japan Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018 - 2030 (USD Million)
Table 32 Japan Bispecific Antibody Therapeutics Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
Table 33 China Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration Type, 2018 - 2030 (USD Million)
Table 34 China Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018 - 2030 (USD Million)
Table 35 China Bispecific Antibody Therapeutics Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
Table 36 Rest of Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration Type, 2018 - 2030 (USD Million)
Table 37 Rest of Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018 - 2030 (USD Million)
Table 38 Rest of Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
Table 39 Rest of Rest of the World Bispecific Antibody Therapeutics Contract Manufacturing Market, by region, 2018 - 2030 (USD Million)
Table 40 Rest of Rest of the World Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration Type, 2018 - 2030 (USD Million)
Table 41 Rest of Rest of the World Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018 - 2030 (USD Million)
Table 42 Rest of Rest of the World Bispecific Antibody Therapeutics Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Market research approaches
Fig. 4 QFD modeling for market share assessment
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Primary research pattern
Fig. 8 Primary interviews in North America
Fig. 9 Primary interviews in Europe
Fig. 10 Primary interviews in the Asia Pacific
Fig. 11 Primary interviews in Latin America
Fig. 12 Primary interviews in MEA
Fig. 13 Market Snapshot
Fig. 14 Segment Snapshot
Fig. 15 Segment Snapshot
Fig. 16 Competitive Landscape Snapshot
Fig. 17 Bispecific Antibody Therapeutics Contract Manufacturing Market segmentation
Fig. 18 Parent market outlook (2022)
Fig. 19 Related/ancillary market outlook (2022)
Fig. 20 Market driver relevance analysis (Current & future impact)
Fig. 21 Current shared services and outsourcing usage levels
Fig. 22 Market restraint relevance analysis (Current & future impact)
Fig. 23 Porter’s five forces analysis
Fig. 24 SWOT analysis, by a factor (political & legal, economic and technological)
Fig. 25 Bispecific Antibody Therapeutics Contract Manufacturing Market Indication outlook: Segment dashboard
Fig. 26 Bispecific Antibody Therapeutics Contract Manufacturing:Indication movement analysis
Fig. 27 Cancer market, 2018 - 2030 (USD Million)
Fig. 28 Infectious Diseases market, 2018 - 2030 (USD Million)
Fig. 29 Autoinflammatory and autoimmune diseases market, 2018 - 2030 (USD Million)
Fig. 30 CNS Conditions market, 2018 - 2030 (USD Million)
Fig. 31 Others market, 2018 - 2030 (USD Million)
Fig. 32 Bispecific Antibody Therapeutics Contract Manufacturing Market Route of Administration type outlook: Segment dashboard
Fig. 33 Bispecific Antibody Therapeutics Contract Manufacturing: Route of Administrationtype movement analysis
Fig. 34 Intravenous market, 2018 - 2030 (USD Million)
Fig. 35 Subcutaneous market, 2018 - 2030 (USD Million)
Fig. 36 Others market, 2018 - 2030 (USD Million)
Fig. 37 Bispecific Antibody Therapeutics Contract Manufacturing Market End Use outlook: Segment dashboard
Fig. 38 Bispecific Antibody Therapeutics Contract Manufacturing Market: End Use movement analysis
Fig. 39 Pharmaceutical Companies market, 2018 - 2030 (USD Million)
Fig. 40 Biopharmaceutical Companies market, 2018 - 2030 (USD Million)
Fig. 41 Others market, 2018 - 2030 (USD Million)
Fig. 42 Regional marketplace: Segment dashboard
Fig. 43 Regional outlook, 2022 & 2030
Fig. 44 North America market, 2018 - 2030 (USD Million)
Fig. 45 U.S. market, 2018 - 2030 (USD Million)
Fig. 46 Canada market, 2018 - 2030 (USD Million)
Fig. 47 Europe market, 2018 - 2030 (USD Million)
Fig. 48 UK market, 2018 - 2030 (USD Million)
Fig. 49 Germany market, 2018 - 2030 (USD Million)
Fig. 50 Rest of Europe market, 2018 - 2030 (USD Million)
Fig. 51 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 52 China market, 2018 - 2030 (USD Million)
Fig. 53 Japan market, 2018 - 2030 (USD Million)
Fig. 54 Rest of Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 55 Rest of Rest of the World market, 2018 - 2030 (USD Million)